Comparison of the bronchodilating effects of albuterol delivered by valved vs. non-valved spacers in pediatric asthma

Simple item page
dc.contributor.authorRodriguez-Martinez, Carlos E.
dc.contributor.authorSossa-Briceño, Monica P.
dc.contributor.authorCastro Rodríguez, José Antonio
dc.date.accessioned2021-12-06T12:29:42Z
dc.date.available2021-12-06T12:29:42Z
dc.date.issued2012
dc.description.abstractIntroduction: Inhaled therapy using a metered-dose inhaler (MDI) with attachedvalved holding chamber has been increasingly recognized as the optimal method fordelivering bronchodilators for asthma treatment. However, mainly due to the highcost of these valved holding chambers in many developing countries, the use of non-valved spacers is frequent, despite the scarce evidence that supports their efficacy. Theaim of this study was to compare the bronchodilator response to albuteroladministered by MDI with and without a valved spacer.Methods: In a randomized, two-period, two-sequence crossover clinical trial, weanalyzed 31 stable asthmatic children (6–18 yrs of age) on two consecutive days, whowere randomly assigned to receive 100 lg of albuterol MDI through either a locallyproduced valved spacer or a non-valved spacer. The next day, a crossover treatmentwas employed through the use of the other spacer. Spirometry was recorded beforeand after each albuterol administration.Results: As we were not able to identify any sequence or carryover effect, we tested fortreatment effects in both periods. No significant differences in the absolute change inFEV1(0.20 ± 0.17 vs. 0.18 ± 0.16, p = 0.63), FVC (0.07 ± 0.13 vs. 0.07 ± 0.16,p = 0.88), or MMEF (0.49 ± 0.31 vs. 0.43 ± 0.39, p = 0.53) after bronchodilatoradministration were found between the use of valved and non-valved spacers.Conclusions: In stable asthmatic children, albuterol administered through MDI usinga non-valved spacer produces a bronchodilator response similar to that of a spacerwith a valve that requires an inhalatory opening pressure (with flows between 2 and32 l/min) that even toddlers with bronchial obstruction can easily generate.
dc.fuente.origenORCID
dc.identifier.doi10.1111/pai.12008
dc.identifier.issn0905-6157
dc.identifier.urihttps://www.doi.org/10.1111/pai.12008
dc.identifier.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-84868204570&partnerID=MN8TOARS
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/63013
dc.information.autorucEscuela de medicina ; Castro Rodríguez, José Antonio ; 0000-0002-0708-4281 ; 113247
dc.issue.numeroNo. 7
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final635
dc.pagina.inicio629
dc.provenancengjara 2021-12-06 09:29:41
dc.relation.isformatofPediatric Allergy and Immunology, vol. 23, no. 7 (nov. 2012), pp. 629-635.
dc.revistaPediatric Allergy and Immunology
dc.rightsacceso abierto
dc.subjectAsthma
dc.subjectPediatrics
dc.subjectTherapeutics
dc.subjectInhalation spacers
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherMedicina y salud
dc.titleComparison of the bronchodilating effects of albuterol delivered by valved vs. non-valved spacers in pediatric asthma
dc.typeartículo
dc.volumenVol. 23
sipa.codpersvinculados113247
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
pai.12008.pdf
Size:
269.5 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas